Cite

MLA Citation

    Marion Oberlé et al.. “Response to BRAF and MEK Inhibitors in BRAF Thr599dup–Mutated Melanoma.” JCO precision oncology, vol. 6, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100152996875.0x000006
  
Back to record